Skip to main content

CFB 135 Pill - blue & yellow capsule/oblong, 21mm

Pill with imprint CFB 135 is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Aurobindo Pharma Limited.

Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CFB 135

Fenofibric acid delayed-release 135 mg CFB 135

Fenofibric Acid Delayed-Release

CFB 135
135 mg
Blue & Yellow
21.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.